Biocompatible Ionic Liquids: A New Approach for Stabilizing Proteins in Liquid Formulation
被引:83
作者:
Vrikkis, Regina M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Dept Mech Engn, Charlotte, NC 28223 USAUniv N Carolina, Dept Mech Engn, Charlotte, NC 28223 USA
Vrikkis, Regina M.
[1
]
Fraser, Kevin J.
论文数: 0引用数: 0
h-index: 0
机构:
Monash Univ, Dept Chem, Wellington, Vic 3800, AustraliaUniv N Carolina, Dept Mech Engn, Charlotte, NC 28223 USA
Fraser, Kevin J.
[2
]
Fujita, Kyoko
论文数: 0引用数: 0
h-index: 0
机构:
Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, JapanUniv N Carolina, Dept Mech Engn, Charlotte, NC 28223 USA
Fujita, Kyoko
[3
]
MacFarlane, Douglas R.
论文数: 0引用数: 0
h-index: 0
机构:
Monash Univ, Dept Chem, Wellington, Vic 3800, AustraliaUniv N Carolina, Dept Mech Engn, Charlotte, NC 28223 USA
MacFarlane, Douglas R.
[2
]
Elliott, Gloria D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Dept Mech Engn, Charlotte, NC 28223 USAUniv N Carolina, Dept Mech Engn, Charlotte, NC 28223 USA
Elliott, Gloria D.
[4
]
机构:
[1] Univ N Carolina, Dept Mech Engn, Charlotte, NC 28223 USA
[2] Monash Univ, Dept Chem, Wellington, Vic 3800, Australia
[3] Tokyo Univ Agr & Technol, Dept Biotechnol, Koganei, Tokyo 1848588, Japan
[4] Univ N Carolina, Dept Mech Engn, Charlotte, NC 28223 USA
来源:
JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
|
2009年
/
131卷
/
07期
关键词:
ionic liquids;
biocompatibility;
protein stability;
LYSOZYME;
D O I:
10.1115/1.3156810
中图分类号:
Q6 [生物物理学];
学科分类号:
071011 ;
摘要:
Ionic liquids (ILs) have shown excellent promise as both solutes and solvents for stabilizing proteins at room temperature. Because many modern drugs are protein-based, these stabilizing characteristics have great potential to provide advances in the field of liquid formulation of therapeutic proteins. However, before these developments can be translated into clinical solutions it is essential to establish data related to the biocompatibility of these ILs. The current work investigates the cytotoxicity of several ILs that were rationally synthesized from natural biomolecules and compounds that have already been approved as excipients for drug formulations. The effect of choline dihydrogen phosphate (choline dhp), choline saccharinate, and 1-butyl 3-methyl imidazolium lactate (bmim lactate) on the metabolic activity of a mouse macrophage cell line (J774) was assessed using the reduction in resazurin as an indicator of activity and, by extension, viability. Two formulations of lysozyme (10 mg/ml and 100 mg/ml) in 80 wt % choline dhp (aq) were prepared and the proteins were evaluated for structural stability immediately following formulation and again at 1 month. Equivalent formulations in 0.1 M Na acetate aqueous buffer were evaluated as controls. A differential scanning microcalorimeter (DSC) was used to evaluate the structural stability on the basis of the unfolding temperature and the enthalpy of unfolding, and a micrococcus lysodiekticus activity test was used to evaluate functional activity. All compounds were found to be relatively benign, with toxicity increasing in the order choline dhp <choline saccharinate <bmim lactate. At 1 month lysozyme that had been stored in choline dhp had a higher activity and folded fraction than lysozyme that had been stored in aqueous buffer. These results suggest that biocompatibility and protein stabilization characteristics can be rationally designed into ionic liquids. [DOI: 10.1115/1.3156810]